Skip to content

Retinopathy screening cohort study in adolescents with diabetes

Retinopathy screening cohort study in adolescents with diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092925
Enrollment
Unknown
Registered
2024-11-26
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The most common early clinical manifestations of diabetic retinopathy include microaneurysm formation and intraretinal hemorrhage. Microvascular injury results in retinal capillary nonperfusion, cotton-wool spots, increased number of hemorrhaged, venous abnormalities, and intraretinal microvascular abnormalities (IRMA). At this stage, increased vascular permeability leads to retinal thickening (ed

Interventions

T1DM patients Group:Social determinants of health
T2DM patients Group:Social determinants of health

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 20 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with diabetes in Tianjin Medical University Chu Hsien-I Memorial Hospital; 2.(2) Under 20 years old; 3.(3) Clear consciousness, no mental disease, accessible to communicate; 4.(4) Agree to participate in the study and be able to attend the follow-up on time;

Exclusion criteria

Exclusion criteria: 1. Unwilling or unable to consent to participate in the study, participate in a follow-up visit on time, or return for a scheduled protocol visit; 2.(2) Participated in another clinical trial within 3 months; 3.(3) Patients with severe cardiopulmonary function damage, liver and kidney function damage, and advanced cancer; 4.(4) Patients with severe mental illness;

Design outcomes

Primary

MeasureTime frame
Non-mydriatic fundus photography;Visual acuity;Optical coherence tomography and optical coherence tomography angiography (OCTA);

Secondary

MeasureTime frame
Optical biometry;Intraocular pressure;Medical measurement;Fasting blood glucose;Questionnaire survey;Glycosylated hemoglobin;Urine ACR;blood triglyceride;urine creatinine;blood cholesterol;

Countries

China

Contacts

Public ContactLiu Juping

Tianjin Medical University Eye Hospital

tydljp@126.com+86 22 86428817

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026